Publication List 2021

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021

6
(476)
Motizuki M, Koinuma D, Yokoyama T, Itoh Y, Omata C, Miyazono K, Saitoh M, Miyazawa K.
TGF-β-induced cell motility requires down-regulation of ARHGAPs to sustain Rac1 activity.
J Biol Chem. 2021 in press.
5
(475)
Kubota SI, Takahashi K, Mano T, Matsumoto K, Katsumata T, Shi S, Tainaka K, Ueda HR, Ehata S, Miyazono K.
Whole-organ analysis of TGF-β-mediated remodelling of the tumour microenvironment by tissue clearing.
Commun Biol. 2021 Mar 5;4(1):294.
4
(474)
Yamamoto H, Sakai N, Ohte S, Sato T, Sekimata K, Matsumoto T, Nakamura K, Watanabe H, Mishima-Tsumagari C, Tanaka A, Hashizume Y, Honma T, Katagiri T, Miyazono K, Tomoda H, Shirouzu M, Koyama H.
Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva.
Bioorg Med Chem Lett. 2021 Apr 15;38:127858.
3
(473)
Kok SY, Oshima H, Takahashi K, Nakayama M, Murakami K, Ueda HR, Miyazono K, Oshima M.
Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation.
Nat Commun. 2021 Feb 8;12(1):863.
2
(472)
Tamura Y, Morikawa M, Tanabe R, Miyazono K, Koinuma D.
Anti-pyroptotic function of TGF-β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells.
Mol Oncol. 2021 in press.
1
(471)
Takahashi K, Ehata S, Miyauchi K, Morishita Y, Miyazawa K, Miyazono K.
Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
Mol Oncol. 2021 Jan;15(1):151-166.